z-logo
open-access-imgOpen Access
Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
Author(s) -
Diogo Alpuim Costa,
Susana Baptista de Almeida,
Pedro C. Barata,
A. Quintela,
Pedro Cabral,
Ana Afonso,
João Maia Silva
Publication year - 2018
Publication title -
gazeta médica/gazeta médica
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2184-0628
pISSN - 2183-8135
DOI - 10.29315/gm.v5i1.147
Subject(s) - medicine , tyrosine kinase , leukocytoclastic vasculitis , renal cell carcinoma , cancer research , tyrosine kinase inhibitor , dermatology , vasculitis , cancer , receptor , disease
A 66-year-old patient with metastatic renal clear cell carcinoma, developed palpable purpura during systemic treatment with different tyrosine kinase inhibitors (TKI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here